Lofexidine
USWM-LX1-3003-2
Phase 3 small_molecule completed
Quick answer
Lofexidine for Opioid Withdrawal is a Phase 3 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Opioid Withdrawal
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed